Disease_Has_Primary_Anatomic_Site Disease_Has_Normal_Tissue_Origin Disease_Has_Normal_Cell_Origin Disease_Has_Abnormal_Cell Disease_Excludes_Primary_Anatomic_Site NCI CTEP Simplified Disease Classification Terminology NCI CTEP SDC Liver and Hepatobiliary Cancer Sub-Category Terminology CTRP Terminology CTRP Disease Terminology Liver Hepatocyte NCIt Neoplasm Core Terminology Intrahepatic Bile Duct Clinical Trials Search-Application Programming Interface Disease Category Terminology CTS-API Disease Main Type Terminology CPTAC Terminology CPTAC Baseline Medical Forms Terminology CPTAC Neoplasms Codelist CPTAC Liver Hepatocellular Carcinoma Baseline Form GDC Terminology CPTAC Codelists Terminology Cellosaurus Disease Terminology Mapped ICDO3.1 Terminology Mapped ICDO3.2 Terminology Mapped ICDO3.1 Morphology Terminology Mapped ICDO3.1 Morphology PT Terminology Mapped ICDO3.2 Morphology Terminology Mapped ICDO3.2 Morphology PT Terminology Histology ICD-O Morphology Code GDC Value Terminology ICD-O-3 Morphology Term Diagnosis Question mCode Terminology mCode Elixhauser Malignant Solid Tumors without Metastases Value Set mCode Primary Malignant Neoplasm Disorder Value Set mCode Primary Cancer Disorder Value Set mCode Cancer Disorder Value Set Digestive System Adenocarcinoma Hepatocellular Carcinoma Hepatocarcinoma Liver Cell Carcinoma Primary Carcinoma of Liver Cells Cellosaurus GDC Carcinoma of the Liver Cells CTRP hepatocellular carcinoma Neoplastic Process Hepatoma, NOS Malignant neoplasm: Liver cell carcinoma Hepatocellular carcinoma, NOS 8170/3 mCode CDISC C3099 Hepatocellular Cancer 8170/3 hepatoma Malignant Carcinoma of Liver Cells C0019204 CARCINOMA, HEPATOCELLULAR, MALIGNANT Hepatoma, malignant Hepatocellular Carcinoma LIHC A type of adenocarcinoma and the most common type of liver tumor. Liver Cell Cancer (Hepatocellular Carcinoma) Liver cell carcinoma Hepatoma Hepatocellular Carcinoma Primary Carcinoma of the Liver Cells A malignant neoplasm arising from hepatocytes. CPTAC CTEP Hepatocellular Carcinoma A malignant tumor that arises from hepatocytes. Hepatocellular carcinoma is relatively rare in the United States but very common in all African countries south of the Sahara and in Southeast Asia. Most cases are seen in patients over the age of 50 years, but this tumor can also occur in younger individuals and even in children. Hepatocellular carcinoma is more common in males than females and is associated with hepatitis B, hepatitis C, chronic alcohol abuse and cirrhosis. Serum elevation of alpha-fetoprotein occurs in a large percentage of patients with hepatocellular carcinoma. Grossly, hepatocellular carcinoma may present as a single mass, as multiple nodules, or as diffuse liver involvement. Microscopically, there is a wide range of differentiation from tumor to tumor (well differentiated to poorly differentiated tumors). Hepatocellular carcinomas quickly metastasize to regional lymph nodes and lung. The overall median survival of untreated liver cell carcinoma is about 4 months. The most effective treatment of hepatocellular carcinoma is complete resection of the tumor. Lately, an increasing number of tumors have been treated with liver transplantation. Hepatocellular_Carcinoma Hepatocellular carcinoma Liver cell carcinoma HCC Hepatic Tissue Adenocarcinoma Cell Clinical Data Interchange Standards Consortium Terminology CDISC SEND Terminology Liver Carcinoma CDISC SEND Tumor Findings Results Terminology Solid Neoplasm